Search Results for: KL1333


KL1333 is a small molecule medicine developed by Yungjin Pharm to treat mitochondrial diseases. It is now in-licensed to NeuroVive Pharmaceutical for clinical development. KL1333 could be used to ... Read more


NVP015 is a program aimed at developing a systemic treatment for patients with genetic mitochondrial neurological diseases such as Leigh syndrome, and MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like ... Read more